TrialThe Journal of infectious diseases2017

Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults.

Scott A Halperin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.